Arrowhead Pharmaceuticals to Participate in Upcoming September 2020 Conferences

On September 8, 2020 Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported that it is scheduled to participate in the following upcoming events (Press release, Arrowhead Pharmaceuticals, SEP 8, 2020, View Source [SID1234564758]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Virtual Conference

September 9, 2020 – Arrowhead management will participate in investor meetings

Baird’s 2020 Global Healthcare Conference

September 10, 2020, 2:00 p.m. EDT – Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation

H.C. Wainwright 22nd Annual Global Investment Conference

September 15, 2020, 9:30 a.m. EDT – Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation

Cantor Fitzgerald Global Healthcare Conference 2020

September 15, 2020, 2:00 p.m. EDT – Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation

A copy of the presentation materials may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.